- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cedara gains FDA nod for Web-enabled viewer
The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired
The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired from multiple modalities (such as x-ray, echocardiography, and CT). The viewer supports both static and dynamic (cine) views and has a plug-in architecture, enabling integration of the viewer into other, third-party, products. The Canadian company plans to develop noncardiology applications for the viewer as well.
© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 5.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
